| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594402 | American Heart Journal | 2017 | 28 Pages |
Abstract
The DAPT-STEMI trial aims to assess in STEMI patients treated with second-generation DESs whether discontinuation of DAPT after 6 months of event-free survival is noninferior to routine 12-month DAPT.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Elvin MD, PhD, Enrico MD, Martin MD, PhD, Mark W. MB, BCh, BAO, Pawel MD, PhD, Clemens MD, PhD, Stéphane MD, PhD, Hans PhD, Felix MD, PhD,